Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan G Ball

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Primary Care Companion for CNS Disorders|March 29, 2012
Efficacy of duloxetine on painful physical symptoms in major depressive disorder for patients with clinically significant painful physical symptoms at baseline: a meta-analysis of 11 double-blind, placebo-controlled clinical trialsSusan G Ball, Durisala Desaiah, Melissa E Spann, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 4, 2007
Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physiciansHannu Koponen, Christer Allgulander, Janelle Erickson, et al.
Depression and Anxiety|December 5, 2009
Current perspectives of the roles of the central norepinephrine system in anxiety and depressionAndrew W Goddard, Susan G Ball, James Martinez, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 31, 2009
Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHDCraig Donnelly, Mark Bangs, Paula Trzepacz, et al.
Human Psychopharmacology|June 17, 2011
Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorderJ Alexander Bodkin, Christer Allgulander, Pierre M Llorca, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 19, 2008
Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trialJonathan R T Davidson, Hans-Ulrich Wittchen, Pierre-Michel Llorca, et al.
The Journal of Clinical Psychiatry|May 4, 2007
Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studiesJean Endicott, James M Russell, Joel Raskin, et al.
Psychotherapy and Psychosomatics|September 14, 2017
Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical StudiesChristopher E M Griffiths, Maurizio Fava, Andrew H Miller, et al.
JAMA Dermatology|August 9, 2023
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 TrialsJustin M Ko, Tiffany T Mayo, Wilma F Bergfeld, et al.
Journal of Attention Disorders|October 31, 2007
Functional outcomes in the treatment of adults with ADHDLenard A Adler, Thomas J Spencer, Louise R Levine, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Primary Care Companion for CNS Disorders|March 29, 2012
Efficacy of duloxetine on painful physical symptoms in major depressive disorder for patients with clinically significant painful physical symptoms at baseline: a meta-analysis of 11 double-blind, placebo-controlled clinical trialsSusan G Ball, Durisala Desaiah, Melissa E Spann, et al.
Primary Care Companion to the Journal of Clinical Psychiatry|July 4, 2007
Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physiciansHannu Koponen, Christer Allgulander, Janelle Erickson, et al.
Depression and Anxiety|December 5, 2009
Current perspectives of the roles of the central norepinephrine system in anxiety and depressionAndrew W Goddard, Susan G Ball, James Martinez, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 31, 2009
Safety and tolerability of atomoxetine over 3 to 4 years in children and adolescents with ADHDCraig Donnelly, Mark Bangs, Paula Trzepacz, et al.
Human Psychopharmacology|June 17, 2011
Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorderJ Alexander Bodkin, Christer Allgulander, Pierre M Llorca, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 19, 2008
Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trialJonathan R T Davidson, Hans-Ulrich Wittchen, Pierre-Michel Llorca, et al.
The Journal of Clinical Psychiatry|May 4, 2007
Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studiesJean Endicott, James M Russell, Joel Raskin, et al.
Psychotherapy and Psychosomatics|September 14, 2017
Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical StudiesChristopher E M Griffiths, Maurizio Fava, Andrew H Miller, et al.
JAMA Dermatology|August 9, 2023
Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata: A Pooled Analysis of the BRAVE-AA1 and BRAVE-AA2 TrialsJustin M Ko, Tiffany T Mayo, Wilma F Bergfeld, et al.
Journal of Attention Disorders|October 31, 2007
Functional outcomes in the treatment of adults with ADHDLenard A Adler, Thomas J Spencer, Louise R Levine, et al.
Pageof 3